» Articles » PMID: 38641581

Trends in Parkinson's Disease Mortality in China from 2004 to 2021: a Joinpoint Analysis

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Apr 19
PMID 38641581
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to analyze the trends of Parkinson's disease (PD) mortality rates among Chinese residents from 2004 to 2021, provide evidence for the formulation of PD prevention and control strategies to improve the quality of life among PD residents.

Methods: Demographic and sociological data such as gender, urban or rural residency and age were obtained from the National Cause of Death Surveillance Dataset from 2004 to 2021. We then analyzed the trends of PD mortality rates by Joinpoint regression.

Results: The PD mortality and standardized mortality rates in China showed an overall increasing trend during 2004-2021 (average annual percentage change [AAPC] = 7.14%, AAPC=3.21%, P < 0.001). The mortality and standardized mortality rate in male (AAPC = 7.65%, AAPC=3.18%, P < 0.001) were higher than that of female (AAPC = 7.03%, AAPC=3.09%, P < 0.001). The PD standardized mortality rates of urban (AAPC = 5.13%, AAPC=1.76%, P < 0.001) and rural (AAPC = 8.40%, AAPC=4.29%, P < 0.001) residents both increased gradually. In the age analysis, the mortality rate increased with age. And the mortality rates of those aged > 85 years was the highest. Considering gender, female aged > 85 years had the fastest mortality trend (annual percentage change [APC] = 5.69%, P < 0.001). Considering urban/rural, rural aged 80-84 years had the fastest mortality trend (APC = 6.68%, P < 0.001).

Conclusions: The mortality rate of PD among Chinese residents increased from 2004 to 2021. Male sex, urban residence and age > 85 years were risk factors for PD-related death and should be the primary focus for PD prevention.

Citing Articles

Chronic obstructive pulmonary disease burden attributable to tobacco and the trend change from 1990 to 2021 in China.

Zhang Z, Wang K, Xu G, Zhang R Tob Induc Dis. 2025; 23.

PMID: 39931132 PMC: 11808299. DOI: 10.18332/tid/200196.


Burden of neurologic diseases in BRICS countries (1990 to 2021): an analysis of 2021 Global Burden of Disease Study.

Chauhan S, Gaidhane S, Priya G, Sharma P, Bhat M, Sharma S Front Neurol. 2024; 15:1500551.

PMID: 39703360 PMC: 11655333. DOI: 10.3389/fneur.2024.1500551.

References
1.
Timblin H, Rahmani E, Ryczek C, Hill C, Jones J . Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson's disease. Neuropsychology. 2022; 36(6):505-512. PMC: 9620779. DOI: 10.1037/neu0000837. View

2.
Peretz C, Rozani V, Giladi N, El-Ad B, Tsamir J, Hemo B . The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study. Neuroepidemiology. 2019; 53(1-2):13-19. DOI: 10.1159/000492672. View

3.
Ye H, Robak L, Yu M, Cykowski M, Shulman J . Genetics and Pathogenesis of Parkinson's Syndrome. Annu Rev Pathol. 2022; 18:95-121. PMC: 10290758. DOI: 10.1146/annurev-pathmechdis-031521-034145. View

4.
Peacock D, Baumeister P, Monaghan A, Siever J, Yoneda J, Wile D . Perception of Healthcare Access and Utility of Telehealth Among Parkinson's Disease Patients. Can J Neurol Sci. 2020; 47(5):700-704. DOI: 10.1017/cjn.2020.99. View

5.
Johansson M, Cameron I, van der Kolk N, de Vries N, Klimars E, Toni I . Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial. Ann Neurol. 2021; 91(2):203-216. PMC: 9306840. DOI: 10.1002/ana.26291. View